Search Results  for 'ALGETA.OL'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Algeta ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

05 Apr 2014 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Algeta Asa

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Mar 2014 Wright Reports 42 $75.00

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review Summary Algeta ASA (Algeta) is a pharmaceutical company wi...

28 Feb 2014 GlobalData 43 $125.00

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review Summary Algeta ASA (Algeta) is a pharmaceutical company wi...

25 Feb 2014 GlobalData 43 $125.00

Laidlaw Dropping Coverage of Algeta Due to Acquisition By Bayer

Laidlaw Dropping Coverage of Algeta Due to Acquisition By Bayer

21 Feb 2014 Laidlaw & Company 5 $10.00

Algeta ASA (ALGETA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Algeta ASA (ALGETA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Algeta ASA (Algeta) is a pharmaceuti...

12 Feb 2014 GlobalData 31 $250.00

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review Summary Algeta ASA (Algeta) is a pharmaceutical company wi...

10 Jan 2014 GlobalData 42 $125.00

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review

Algeta ASA (ALGETA) - Financial and Strategic SWOT Analysis Review Summary Algeta ASA (Algeta) is a pharmaceutical company wi...

17 Dec 2013 GlobalData 44 $125.00

Bayer Makes Bid for Algeta; Lowering Rating to Hold from Buy

The Board of Directors of Algeta ASA announced that it is in receipt of a preliminary acquisition proposal from Bayer AG, Alg...

26 Nov 2013 Laidlaw & Company 9 $25.00

Highlights From Algeta Analyst Day In New York

Management updated investors on the status of the Xofigo launch, the next studies to add new indications for the drug, an upd...

22 Nov 2013 Laidlaw & Company 10 $25.00